Toronto, Ontario--(Newsfile Corp. - November 14, 2013) - Ubika Research has released the next report in the "Ubika Growth 20" series. This week they focus on the healthcare sector with the release of the "Ubika Growth 20: Healthcare " report, featuring the fastest-growing healthcare companies. Included in this week's list is an 89%, three-month gain in the share price of Paladin Labs Inc (TSX: PLB) (CSE: PLB), after the Canadian specialty drug maker agreed to be acquired by Endo Health for $1.5 billion in cash and stock.
You can get your copy of the report here: http://www.smallcappower.com/posts/ubika-healthcare-growth-20-report-14-11-2013.
Some of the highest ranked companies in the Ubika Healthcare Growth 20 include Paladin Labs Inc (TSX: PLB) (CSE: PLB), CryoLife Inc (NYSE: CRY), and Rochester Medical Corp (NASDAQ: ROCM).
See the performance ranking of all the companies in the Ubika Healthcare Growth 20 here:
About the Ubika Growth 20
It is difficult for an individual investor to review and identify the many excellent growth opportunities available in the smallcap universe. Fortunately, investors now have access to the information that was previously only available to sophisticated investment professionals. Ubika Research analysts do their due diligence and review fundamental indicators like revenue growth, operating cash flow growth and P/E to bring you their best performing picks and present them in the Ubika Growth 20.
Our analysts have divided smallcap companies in the US and Canada with market caps of $10 million - $5 billion market cap into 6 sectors: Diversified Mining, Energy, Technology, Industrials, Health Care and Financials. Then Ubika created a balanced scorecard to rank the smallcap companies that meet their proprietary growth criteria. The Ubika Growth 20 report will short list the top companies that meet our criteria in a particular sector. Apart from providing the fundamental data like sales growth, operating cash flow growth and trailing P/E, our report also provides investors with a short description of the 20 individual companies.
The Ubika Growth 20 provides the investors with an excellent starting point to identify fast growing small cap companies in a variety of sectors. Investors are encouraged to follow the links provided to the SmallCapPower company pages to learn more.
About Ubika Research
Ubika Research is an investment research and capital market services firm based in Toronto with a proven track record of identifying and launching coverage of high potential small cap stocks (<$5 billion) at an early stage. For more information visit www.ubikaresearch.com.
Disclosure
Except for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
Ubika Research and www.smallcappower.com (are both divisions of Ubika Corporation), and are not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice. For full disclosure please visit: http://www.smallcappower.com/pages/small-cap-power-disclosure.
For additional information contact:
SmallCapPower- info@smallcappower.com
